搜索临床试验以:polymerase (PARP)
总计1527个结果
-
Tianjin Medical University Cancer Institute and...招聘中
-
Sidney Kimmel Comprehensive Cancer Center at Johns...AstraZeneca; The Marcus Foundation; McGuff Pharmaceuticals, Inc.招聘中
-
Centre de Recherche Médicale de LambarénéInstitute of Tropical Medicine, University of Tuebingen尚未招聘
-
University of Michigan Rogel Cancer CenterPfizer; Acrotech Biopharma Inc.招聘中
-
Cancer Institute and Hospital, Chinese Academy...招聘中化疗毒性 | 放射治疗;并发症 | PARP抑制剂 | 免疫检查点抑制剂 | 曲妥珠单抗 | 乳腺癌,家族性男性 | CDK4/6 抑制剂 | 帕妥珠单抗中国
-
Jennifer Lauren KamensGateway for Cancer Research招聘中
-
Rhizen Pharmaceuticals SA完全的实体瘤 | 转移性乳腺癌 | 局部晚期乳腺癌 | 广泛期小细胞肺癌 | 铂敏感性输卵管癌 | 铂敏感卵巢癌 | 铂敏感腹膜癌捷克语, 波兰
-
Hoosier Cancer Research NetworkClovis Oncology, Inc.完全的
-
Ronald BuckanovichGenentech, Inc.招聘中
-
Centre Francois BaclesseNational Cancer Institute, France招聘中
-
University of Alabama at Birmingham撤销
-
Inotek Pharmaceuticals Corporation完全的
-
University of Texas Southwestern Medical Center撤销
-
Tesaro, Inc.撤销
-
Gustave Roussy, Cancer Campus, Grand ParisMerck Sharp & Dohme LLC尚未招聘
-
Paul Mathew, MDHoosier Cancer Research Network; Tesaro, Inc.终止
-
Yonsei UniversityTakeda招聘中既往接受过 PARP 抑制剂治疗的铂敏感复发性卵巢癌患者大韩民国
-
AbbVie (prior sponsor, Abbott)完全的脑部疾病 | 中枢神经系统疾病 | 肿瘤转移 | 脑肿瘤 | 神经系统肿瘤美国, 加拿大, 波多黎各
-
National Cancer Institute (NCI)主动,不招人
-
Atridia Pty Ltd.完全的
-
Jonsson Comprehensive Cancer CenterPfizer; Translational Research in Oncology招聘中
-
Abramson Cancer Center at Penn Medicine主动,不招人
-
University Medical Center GroningenAbbVie; Dutch Cancer Society撤销
-
National Cancer Institute (NCI)终止
-
Duke UniversityAstraZeneca完全的
-
Seoul National University HospitalSamsung Medical Center; Takeda; Asan Medical Center; Yonsei University尚未招聘卵巢癌 | 上皮性卵巢癌 | 卵巢癌第四期 | 卵巢癌 III 期
-
Yonsei UniversityCanariaBio Inc.招聘中PARP 抑制剂耐药的卵巢癌、输卵管癌或原发性腹膜癌患者不适合铂类再治疗大韩民国
-
The University of Hong Kong招聘中复发性胶质母细胞瘤 | 复发性胶质瘤 | 聚 ADP 核糖聚合酶 (PARP) 抑制剂 | PTEN基因失活 | IDH突变香港